Fast Track CSII Using a Novel Device in Young Children With Newly Diagnosed T1DM

Completed · Not applicable

Conditions studied: Type 1 Diabetes Mellitus

In brief

This study evaluates early initiation of continuous subcutaneous insulin infusion (CSII) therapy in young children using a novel delivery method in the form of a self-contained, lightweight, and disposable insulin pump unit controlled with a wireless handheld device. The outcomes of interest are the feasibility and potential metabolic benefits of this approach. We anticipate that the initiation of this CSII device in the immediate post-diagnosis period in this population will result in good glycemic control and greater parental satisfaction when compared to intensive insulin injection therapy.

Key facts

Study ID
NCT00476788
Run by
University of Alabama at Birmingham
People needed
14
Starts
2007-04-01
Expected to finish
2009-09-01
Last updated by the study team
2017-04-17

Who can join

Age: 1 and older, up to 8. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.